{
    "nctId": "NCT06615466",
    "briefTitle": "Super-Hypofractionated Partial Breast Irradiation",
    "officialTitle": "Super-Hypofractionated Partial Breast Irradiation After Breast-Conserving Surgery for Early-Stage Low-Risk Breast Cancer: a Prospective, Single-arm Trial",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Radiotherapy Side Effect",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Incidence of acute adverse reactions",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. \u226545 years old, \\<75 years old women\n2. Life expectancy \\>5 years\n3. Start radiotherapy within 12 weeks after breast-conserving surgery (or within 8 weeks from the end of chemotherapy)\n4. Invasive ductal carcinoma grade 1-2, or mucinous carcinoma, papillary carcinoma, canalicular carcinoma, medullary carcinoma; primary tumor\n\n   \u22643.0cm; both pN0 (axillary dissection or sentinel lymph node biopsy)\n5. Low-risk DCIS: tumor \u22642.5cm, low to medium grade; axillary surgery is not required or pN0\n6. Single focus (with MRI diagnosis)\n7. Vascular tumor thrombus negative\n8. ER and/or PR positivity (defined as strong positivity in \\>1% of tumor cell nuclei)\n9. Negative pathological margin\u22652mm\n10. Place metal markers on the tumor bed\n11. Sign the informed consent form\n\nExclusion Criteria:\n\n1. Multiple primary tumors\n2. Invasive ductal carcinoma grade 3\n3. Invasive micropapillary carcinoma\n4. Lobular carcinoma in situ\n5. Invasive lobular carcinoma\n6. Simple nipple paget's disease\n7. Oncoplastic surgery\n8. Neoadjuvant chemotherapy or neoadjuvant endocrine therapy\n9. Previous or simultaneous contralateral breast cancer\n10. History of ipsilateral chest wall radiotherapy\n11. Have active collagen vascular disease",
    "sex": "FEMALE",
    "minimumAge": "45 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}